Experts and Doctors on cardiovascular diseases in Innsbruck, Tyrol, Austria

Summary

Locale: Innsbruck, Tyrol, Austria
Topic: cardiovascular diseases

Top Publications

  1. Hogl B. Periodic limb movements are associated with disturbed sleep. Pro. J Clin Sleep Med. 2007;3:12-4 pubmed
  2. Strasak A, Kelleher C, Klenk J, Brant L, Ruttmann E, Rapp K, et al. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol. 2008;28:1857-65 pubmed publisher
    ..Our study is the first to demonstrate that a longitudinal increase in GGT, independently of baseline GGT and even within its normal range, significantly increases risk of fatal CVD. ..
  3. Rudnicki M, Mayer G. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics. 2009;10:463-76 pubmed publisher
    ..However, as race and environmental factors, such as salt intake also affect treatment response most studies were underpowered leading to conflicting results. ..
  4. Resch T, Pircher A, Kähler C, Pratschke J, Hilbe W. Endothelial progenitor cells: current issues on characterization and challenging clinical applications. Stem Cell Rev. 2012;8:926-39 pubmed publisher
    ..In this current review, an overview on recent findings on EPC biology is given, their challenging clinical implications are discussed and the perplexity underlying the current controversial debate is illustrated. ..
  5. Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy. Antivir Ther. 2012;17:1021-7 pubmed publisher
    ..Thus, it is unlikely that disturbances of dimethylarginine metabolism account for the increased risk of cardiovascular events of HIV-infected patients under ART. ..
  6. Macdougall I, Bircher A, Eckardt K, Obrador G, Pollock C, Stenvinkel P, et al. Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney Int. 2016;89:28-39 pubmed publisher
    ..Therefore, an expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects. ..
  7. März W, Scharnagl H, Gouni Berthold I, Silbernagel G, Dressel A, Grammer T, et al. LDL-Cholesterol: Standards of Treatment 2016: A German Perspective. Am J Cardiovasc Drugs. 2016;16:323-36 pubmed publisher
  8. Fuchs D, Avanzas P, Arroyo Espliguero R, Jenny M, Consuegra Sanchez L, Kaski J. The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem. 2009;16:4644-53 pubmed
    ..The present article reviews the role of neopterin in the pathogenesis of cardiovascular disease and as a marker of coronary artery disease progression. ..
  9. Gelsinger C, Tschoner A, Kaser S, Ebenbichler C. [Adipokine update - new molecules, new functions]. Wien Med Wochenschr. 2010;160:377-90 pubmed publisher
    ..This review aims to characterize novel, newly recognized adipokines and to discuss their roles in the pathogenesis of insulin resistance and atherosclerosis, as well as other metabolic complications. ..

More Information

Publications16

  1. Fleischhacker W, Siu C, Boden R, Pappadopulos E, Karayal O, Kahn R. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. Int J Neuropsychopharmacol. 2013;16:987-95 pubmed publisher
  2. Melmer A, Lamina C, Tschoner A, Ress C, Kaser S, Laimer M, et al. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors. Obesity (Silver Spring). 2013;21:775-81 pubmed publisher
    ..BAI was inferior to BMI to predict anthropometric parameters other than HC, adiponectin, blood lipids, parameters of glucose homeostasis, and blood pressure in this cross-sectional study. ..
  3. Murr C, Pilz S, Grammer T, Kleber M, Meinitzer A, Boehm B, et al. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem Lab Med. 2012;50:2205-12 pubmed
    ..Our results indicate increased inflammatory processes in patients with low vitamin D status. Further studies should clarify the underlying mechanisms for the observed associations of vitamin D status and inflammatory parameters. ..
  4. Kronenberg F. Lipoprotein(a): there's life in the old dog yet. Circulation. 2014;129:619-21 pubmed publisher
  5. Pechlaner R, Tsimikas S, Yin X, Willeit P, Baig F, Santer P, et al. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III. J Am Coll Cardiol. 2017;69:789-800 pubmed publisher
    ..73). The strong associations of VLDL-associated apolipoproteins with incident CVD in the general community support the concept of targeting triacylglycerol-rich lipoproteins to reduce risk of CVD. ..
  6. Willeit P, Welsh P, Evans J, Tschiderer L, Boachie C, Jukema J, et al. High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants. J Am Coll Cardiol. 2017;70:558-568 pubmed publisher
    ..This association is independent of conventional risk factors, strongest for fatal CVD, and applies to both CHD and stroke. ..
  7. Tschiderer L, Willeit J, Schett G, Kiechl S, Willeit P. Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. PLoS ONE. 2017;12:e0183910 pubmed publisher
    ..05). Elevated osteoprotegerin concentration is associated with an increased risk of incident cardiovascular disease in the general population. The mechanisms underlying this observation deserve further investigation. ..